Polymorphisms of interferon gamma gene and risk of hepatocellular carcinoma in korean patients with chronic hepatitis B viral infection

Hepatogastroenterology. 2013 Jul-Aug;60(125):1117-20. doi: 10.5754/hge11333.

Abstract

Backgrounds/aims: Increasing evidence supports the contribution of the pro-/anti-inflammatory cytokine balance and genetic factors to hepatocellular carcinoma (HCC). Here, we investigated whether genetic interferon gamma polymorphisms were associated with HCC in Korean patients with chronic hepatitis B.

Methodology: We genotyped a single nucleotide polymorphism (SNP, rs2430561, +874A/T) and a microsatellite (rs3138557, (CA)n repeat), located in the first intron of the interferon gamma gene, by direct sequencing and the gene scan method. A population-based case-control study of HCC was conducted and included 170 patients with chronic hepatitis and HCC, and 171 with chronic hepatitis B patients without hepatocellular carcinoma in a Korean population.

Results: Genotype and allele distributions of the interferon gamma gene SNP were associated with HCC. The frequencies of the AA genotype and the A allele were significantly increased in hepatocellular carcinoma subjects (p<0.05). Combined analysis using the genotype of rs2430561 and the number of microsatellites revealed that the frequencies of AT-CA12 and TT-CA12 increased significantly in hepatocellular carcinoma subjects (p<0.0001).

Conclusions: Our results suggest that the interferon gamma gene may be a susceptibility gene and a risk factor for HCC in the Korean population.

MeSH terms

  • Carcinoma, Hepatocellular / etiology*
  • Carcinoma, Hepatocellular / genetics
  • Case-Control Studies
  • Genotype
  • Hepatitis B, Chronic / complications
  • Hepatitis B, Chronic / genetics*
  • Humans
  • Interferon-gamma / genetics*
  • Liver Neoplasms / etiology*
  • Liver Neoplasms / genetics
  • Microsatellite Repeats
  • Polymorphism, Single Nucleotide*
  • Risk

Substances

  • Interferon-gamma